<DOC>
	<DOCNO>NCT00301379</DOCNO>
	<brief_summary>This observational study intend validate result previous study do Mayo Clinic . Patients treated combination chemotherapy radiation maintain oral Xeloda receive liver transplant . A stag laparotomy perform chemoradiation order identify patient benefit treatment improve outcome .</brief_summary>
	<brief_title>Registry Study Neoadjuvant Chemoradiation &amp; Transplant Cholangiocarcinoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<criteria>1 . Diagnosis cholangiocarcinoma establish preoperatively least one follow criterion : 1 . A positive brush cytology biopsy result obtain time cholangiography ; 2 . Fluorescence situ hybridization demonstrate aneuploidy ; 3 . A serum CA 199 value great 100 U/mL presence radiographically characteristic malignant stricture absence cholangitis . 2 . Tumor/stricture cystic duct unresectable . 3 . A suitable candidate orthotopic liver transplantation judge radiation oncologist , medical oncologist , liver transplant team . 4 . &gt; /= 18 year age . 5 . Willing able provide write informed consent . 1 . Intrahepatic metastasis metastatic disease ( except perihilar node ) . 2 . Prior treatment disease ( include attempt resection , irradiation , chemotherapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>Observational</keyword>
</DOC>